| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
hsa_circ_0082003 promotes PTC cell proliferation, migration, invasion, and xenograft tumor growth, and its high expression is associated with aggressive clinicopathological features including lymph node metastasis. |
| Molecular mechanism: |
The exact regulatory mechanism in PTC remains unclear; the study functionally demonstrates an oncogenic role without defining a specific downstream molecular axis. |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RT-qPCR; Sanger Sequencing; Clinical Sample Validation; Transfection; CCK8; Colony Formation Assay; Wound Healing Assay; Transwell Assay; In Vivo Animal Model; ROC Analysis; Bioinformatics Analysis |
| Clinical significance: |
hsa_circ_0082003 has potential as a diagnostic biomarker for PTC and as a marker for lymph node metastasis prediction; high expression correlates with adverse clinicopathological parameters and is an independent predictor of LNM. |
| Description: |
This study identifies hsa_circ_0082003, a MET-derived circRNA, as an up-regulated oncogenic circRNA in papillary thyroid carcinoma. Its knockdown suppresses PTC cell proliferation, migration, invasion, and xenograft tumor growth, while high expression is associated with aggressive clinicopathological features and independently predicts lymph node metastasis. The exact downstream regulatory mechanism in PTC was not defined. |
| Confidence score: |
0.7369 |